{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:14:55Z","timestamp":1726719295690},"reference-count":263,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1055\/a-1589-7854","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T23:38:26Z","timestamp":1644622706000},"page":"e186-e227","source":"Crossref","is-referenced-by-count":3,"title":["S3-Leitlinie \u2013 Diagnostik und Therapie bili\u00e4rer Karzinome"],"prefix":"10.1055","volume":"60","author":[{"given":"M.","family":"Bitzer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Voesch","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Albert","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie, Robert-Bosch-Krankenhaus, Stuttgart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Nuklearmedizin, LMU Klinikum, M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Bechstein","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral-, Transplantations- und Thoraxchirurgie, Universit\u00e4tsklinikum Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bl\u00f6dt","sequence":"additional","affiliation":[{"name":"AWMF-Gesch\u00e4ftsstelle, Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Brunner","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie, Universit\u00e4tsklinikum Magdeburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dombrowski","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4tsmedizin Greifswald"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Evert","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Follmann","sequence":"additional","affiliation":[{"name":"Office des Leitlinienprogrammes Onkologie, c\/o Deutsche Krebsgesellschaft e.V., Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"La Foug\u00e8re","sequence":"additional","affiliation":[{"name":"Nuklearmedizin und Klinische Molekulare Bildgebung, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Freudenberger","sequence":"additional","affiliation":[{"name":"Clinical Guideline Services GmbH, Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Geier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gkika","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlenheilkunde, Department f\u00fcr Radiologische Diagnostik und Therapie, Universit\u00e4tsklinikum Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"G\u00f6tz","sequence":"additional","affiliation":[{"name":"Kliniken B\u00f6blingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hammes","sequence":"additional","affiliation":[{"name":"Lebertransplantierte Deutschland e. V., Ansbach"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Helmberger","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Radiologie, Neuroradiologie und minimal-invasive Therapie, M\u00fcnchen Klinik Bogenhausen, M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institut und Poliklinik f\u00fcr Diagnostische und Interventionelle Radiologie, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. P.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Gastroenterologie am Bayerischen Platz, medizinisches Versorgungszentrum, Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Huppert","sequence":"additional","affiliation":[{"name":"Radiologisches Zentrum, Max Grundig Klinik, B\u00fchl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kautz","sequence":"additional","affiliation":[{"name":"Deutsche Leberhilfe e.V., K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kn\u00f6tgen","sequence":"additional","affiliation":[{"name":"Konferenz onkologischer Kranken- und Kinderkrankenpflege, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"K\u00f6rber","sequence":"additional","affiliation":[{"name":"Klinik Nahetal, Fachklinik f\u00fcr onkologische Rehabilitation und Anschlussrehabilitation, Bad Kreuznach"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Krug","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie, Universit\u00e4tsklinikum Schleswig-Holstein, Kiel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lammert","sequence":"additional","affiliation":[{"name":"Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lang","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral und Transplantationschirurgie, Universit\u00e4tsmedizin der\u00a0Johannes Gutenberg-Universit\u00e4t Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Langer","sequence":"additional","affiliation":[{"name":"Office des Leitlinienprogrammes Onkologie, c\/o Deutsche Krebsgesellschaft e.V., Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lenz","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum M\u00fcnster, Zentrale Einrichtung Palliativmedizin, M\u00fcnster"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mahnken","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Gie\u00dfen und Marburg GmbH, Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meining","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II des Universit\u00e4tsklinikums W\u00fcrzburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Micke","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie und Radioonkologie, Franziskus Hospital Bielefeld"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Allgemein-, Viszeral- und Transplantationschirurgie, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Humangenetik, Ruhr-Universit\u00e4t, Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ockenga","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Klinikum Bremen-Mitte, Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Oldhafer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Leber-, Gallenwegs- und Pankreaschirurgie, Semmelweis Universit\u00e4t, Asklepios Campus Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paprottka","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr interventionelle Radiologie, Klinikum rechts der Isar der Technischen Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Paradies","sequence":"additional","affiliation":[{"name":"Konferenz onkologischer Kranken- und Kinderkrankenpflege, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr interventionelle Radiologie, Klinikum rechts der Isar der Technischen Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Persigehl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Plauth","sequence":"additional","affiliation":[{"name":"St\u00e4dtisches Klinikum Dessau"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Plentz","sequence":"additional","affiliation":[{"name":"Klinikum Bremen-Nord, Innere Medizin, Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pohl","sequence":"additional","affiliation":[{"name":"Interventionelles Endoskopiezentrum und Schwerpunkt Gastrointestinale Onkologie, Asklepios Klinik Altona, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Riemer","sequence":"additional","affiliation":[{"name":"Lebertransplantierte Deutschland e. V., Bretzfeld"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reimer","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr diagnostische und interventionelle Radiologie, St\u00e4dtisches Klinikum Karlsruhe gGmbH, Karlsruhe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ringwald","sequence":"additional","affiliation":[{"name":"Psychosomatische Medizin und Psychotherapie, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Ritterbusch","sequence":"additional","affiliation":[{"name":"Hospizarbeit am Universit\u00e4tsklinikum Essen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Roeb","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Universit\u00e4tsklinikum Gie\u00dfen und Marburg GmbH, Gie\u00dfen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schellhaas","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schirmacher","sequence":"additional","affiliation":[{"name":"Pathologisches Institut, Universit\u00e4tsklinikum Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schmid","sequence":"additional","affiliation":[{"name":"Zentrum P\u00e4diatrische H\u00e4matologie und Onkologie, Dr.\u00a0von\u00a0Haunersches Kinderspital, Klinikum der Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schuler","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, Alb Fils Kliniken GmbH, G\u00f6ppingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"von Schweinitz","sequence":"additional","affiliation":[{"name":"SRH Wilhelm L\u00f6he Hochschule, F\u00fcrth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Seehofer","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Viszeral-, Transplantations-, Thorax- und Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sinn","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Universit\u00e4tsklinikum Hamburg-Eppendorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stein","sequence":"additional","affiliation":[{"name":"H\u00e4matologisch-Onkologischen Praxis Eppendorf, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stengel","sequence":"additional","affiliation":[{"name":"Psychosomatische Medizin und Psychotherapie, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Steubesand","sequence":"additional","affiliation":[{"name":"Clinical Guideline Services GmbH, Kiel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Klinik Herzogh\u00f6he Bayreuth, Bayreuth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tannapfel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie der Ruhr-Universit\u00e4t Bochum am Berufsgenossenschaftlichen Universit\u00e4tsklinikum Bergmannsheil, Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Taubert","sequence":"additional","affiliation":[{"name":"Kliniksozialdienst, Universit\u00e4tsklinikum Heidelberg, Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Trojan","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"van Thiel","sequence":"additional","affiliation":[{"name":"Deutsche Leberhilfe e.V., K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tholen","sequence":"additional","affiliation":[{"name":"Deutscher Verband f\u00fcr Physiotherapie e. V., K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie, Endokrinologie der Medizinischen Hochschule Hannover, Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vogl","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Frankfurt, Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Vorwerk","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie, Universit\u00e4tsklinikum Gie\u00dfen und Marburg GmbH, Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wacker","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie der Medizinischen Hochschule Hannover, Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Waidmann","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie Medizinische Hochschule Hannover, Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wege","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wildner","sequence":"additional","affiliation":[{"name":"Innere Medizin, Krankenh\u00e4user N\u00fcrnberger Land GmbH, Lauf an der Pegnitz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wittekind","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4tsklinikum Leipzig, Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"W\u00f6rns","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Mainz, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Galle","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Mainz, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Malek","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes","volume":"128","author":"E A Atchison","year":"2011","journal-title":"Int J Cancer"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"M B de Valle","year":"2012","journal-title":"Liver Int"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans","volume":"49","author":"H B El-Serag","year":"2009","journal-title":"Hepatology"},{"issue":"59","key":"ref6","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.18632\/oncotarget.20141","article-title":"Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis","volume":"8","author":"Y Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis","volume":"21","author":"W Jing","year":"2012","journal-title":"Eur J Cancer Prev"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"W C Palmer","year":"2012","journal-title":"J Hepatol"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"N Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1746.2008.05689.x","article-title":"Long-term follow up of gallbladder polyps","volume":"24","author":"J Y Park","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/apt.12655","article-title":"Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer","volume":"39","author":"V Nagaraja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"N Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma \u2013 evolving concepts and therapeutic strategies","volume":"15","author":"S Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"S 05","key":"ref14","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"J W Valle","year":"2016","journal-title":"Ann Oncol"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"S Rizvi","year":"2013","journal-title":"Gastroenterology"},{"issue":"03","key":"ref16","first-page":"605","article-title":"Risk Factors for Cholangiocarcinoma in Thailand: A Systematic Review and Meta-Analysis","volume":"19","author":"S Kamsa-ard","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(15)60313-0","article-title":"Clonorchiasis","volume":"387","author":"M B Qian","year":"2016","journal-title":"Lancet"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S2214-109X(16)30301-1","article-title":"Global burden of cancers attributable to liver flukes","volume":"5","author":"M B Qian","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5009\/gnl18339","article-title":"Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study","volume":"13","author":"M S You","year":"2019","journal-title":"Gut Liver"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/bjs.10798","article-title":"Meta-analysis of risk of developing malignancy in congenital choledochal malformation","volume":"105","author":"A Ten Hove","year":"2018","journal-title":"Br J Surg"},{"issue":"31","key":"ref21","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.3748\/wjg.v26.i31.4718","article-title":"Risk of malignancy in Caroli disease and syndrome: A systematic review","volume":"26","author":"R Fahrner","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"M M Claessen","year":"2009","journal-title":"J Hepatol"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"G L Tyson","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djz103","article-title":"Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies","volume":"111","author":"E E McGee","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41395-018-0207-4","article-title":"Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis","volume":"113","author":"J L Petrick","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis","volume":"72","author":"O Clements","year":"2020","journal-title":"J Hepatol"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"M A Schmidt","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"P Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"issue":"S 01","key":"ref29","first-page":"S68","article-title":"[Gallbladder polyps: prevalence and risk factors]","volume":"32","author":"W Kratzer","year":"2011","journal-title":"Ultraschall Med"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11605-013-2170-0","article-title":"Porcelain gallbladder: a benign process or concern for malignancy?","volume":"17","author":"T Schnelldorfer","year":"2013","journal-title":"J Gastrointest Surg"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jamcollsurg.2017.11.026","article-title":"Porcelain Gallbladder: Is Observation a Safe Option in Select Populations?","volume":"226","author":"H DesJardins","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/PAS.0b013e31822179cc","article-title":"Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas","volume":"35","author":"S Patel","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"08","key":"ref33","first-page":"912","article-title":"[Updated S3-Guideline for Prophylaxis, Diagnosis and Treatment of Gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Surgery of the Alimentary Tract (DGAV) \u2013 AWMF Registry 021\/008]","volume":"56","author":"C Gutt","year":"2018","journal-title":"Z Gastroenterol"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"J E Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"ref35","first-page":"1135","article-title":"[Practice guideline autoimmune liver diseases \u2013 AWMF-Reg. No. 021-27]","volume":"55","year":"2017","journal-title":"Z Gastroenterol"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1007\/s00330-017-4742-y","article-title":"Management and follow-up of gallbladder polyps: Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery\u200a-\u200aEuropean Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE)","volume":"27","author":"R Wiles","year":"2017","journal-title":"Eur Radiol"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies","volume":"25","author":"B M Fung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"P Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1751-2980.12311","article-title":"Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy","volume":"17","author":"I Naitoh","year":"2016","journal-title":"J Dig Dis"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.gie.2014.09.017","article-title":"Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis","volume":"81","author":"U Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"ref41","first-page":"265","volume-title":"Tumors of the gallbladder and extrahepatic bile ducts","author":"D S Klimstra","year":"2019"},{"key":"ref42","first-page":"215","volume-title":"Tumors of the liver and intrahepatic bile ducts","author":"V Paradis","year":"2019"},{"issue":"08","key":"ref43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"J Y Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"09","key":"ref44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"H Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"09","key":"ref45","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1046\/j.1365-2168.1998.00815.x","article-title":"Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment","volume":"85","author":"A Sasaki","year":"1998","journal-title":"Br J Surg"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"A Moeini","year":"2017","journal-title":"J Hepatol"},{"key":"ref47","first-page":"499","volume-title":"Other tumours of the digestive system","author":"V Paradis","year":"2019"},{"volume-title":"TNM-Klassifikation maligner Tumoren. (8. Auflage, korrigierter Nachdruck)","year":"2020","author":"C Wittekind","key":"ref48"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-79410-0","volume-title":"Organspezifische Tumordokumentation \u2013 Prinzipien und Verschl\u00fcsselungsanweisungen f\u00fcr Klinik und Praxis. Online-version: deutsche Krebsgesellschaft","author":"G HP Wagner","year":"1995"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-015-1475-7","article-title":"Cohort profile: cholangiocarcinoma screening and care program (CASCAP)","volume":"15","author":"N Khuntikeo","year":"2015","journal-title":"BMC Cancer"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00261-012-9854-x","article-title":"Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis","volume":"38","author":"R Li","year":"2013","journal-title":"Abdom Imaging"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1259\/bjr\/21653786","article-title":"Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination","volume":"85","author":"H X Xu","year":"2012","journal-title":"Br J Radiol"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0034-1399147","article-title":"CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients \u2013 early or late washout matters: a subanalysis of the DEGUM multicenter trial","volume":"36","author":"D Wildner","year":"2015","journal-title":"Ultraschall Med"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiology.201.1.8816536","article-title":"Portal vein evaluation with US: comparison to angiography combined with CT arterial portography","volume":"201","author":"A M Bach","year":"1996","journal-title":"Radiology"},{"key":"ref55","first-page":"CD012233","article-title":"Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps","volume":"8","author":"S Z Wennmacker","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00004728-199909000-00004","article-title":"Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI","volume":"23","author":"Y Zhang","year":"1999","journal-title":"J Comput Assist Tomogr"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00261-012-9964-5","article-title":"Routine use of precontrast and delayed acquisitions in abdominal CT: time for change","volume":"38","author":"P T Johnson","year":"2013","journal-title":"Abdom Imaging"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/hbsn.2016.12.10","article-title":"Multimodality imaging of intrahepatic cholangiocarcinoma","volume":"6","author":"K Fabrega-Foster","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002610000079","article-title":"Intrahepatic peripheral cholangiocarcinoma: CT evaluation","volume":"25","author":"C Valls","year":"2000","journal-title":"Abdom Imaging"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"J H Kim","year":"2011","journal-title":"Am J Roentgenol"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"J Bridgewater","year":"2014","journal-title":"J Hepatol"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jmri.24810","article-title":"MRI of cholangiocarcinoma","volume":"42","author":"K S Jhaveri","year":"2015","journal-title":"J Magn Reson Imaging"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jmri.1880050210","article-title":"Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study","volume":"5","author":"T Murakami","year":"1995","journal-title":"J Magn Reson Imaging"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2214\/ajr.158.1.1309221","article-title":"Intrahepatic cholangiocarcinoma: MR appearance","volume":"158","author":"J Hamrick-Turner","year":"1992","journal-title":"Am J Roentgenol"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2214\/ajr.161.2.8392787","article-title":"Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging","volume":"161","author":"Z M Fan","year":"1993","journal-title":"Am J Roentgenol"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clinimag.2013.12.022","article-title":"MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (<\/=3 cm) with cirrhosis and chronic viral hepatitis: a comparative study","volume":"38","author":"R F Sheng","year":"2014","journal-title":"Clin Imaging"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/rg.293085729","article-title":"Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation","volume":"29","author":"Y E Chung","year":"2009","journal-title":"Radiographics"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00261-012-9943-x","article-title":"Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma","volume":"38","author":"H J Park","year":"2013","journal-title":"Abdom Imaging"},{"issue":"08","key":"ref69","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ejrad.2015.05.003","article-title":"Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging","volume":"84","author":"H E Fattach","year":"2015","journal-title":"Eur J Radiol"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/gastro\/gou057","article-title":"Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis","volume":"3","author":"U Navaneethan","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00261-016-0635-9","article-title":"Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?","volume":"41","author":"J K Pahade","year":"2016","journal-title":"Abdom Radiol (NY)"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00330-014-3097-x","article-title":"The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures","volume":"24","author":"H J Park","year":"2014","journal-title":"Eur Radiol"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.2016151781","article-title":"Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker","volume":"281","author":"J Lee","year":"2016","journal-title":"Radiology"},{"issue":"12","key":"ref74","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2018-316801","article-title":"Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis","volume":"68","author":"C Rupp","year":"2019","journal-title":"Gut"},{"key":"ref75","first-page":"497942","article-title":"Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"2015","author":"H Zhang","year":"2015","journal-title":"Biomed Res Int"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"(18)F-fluorodeoxyglucose positron emission tomography ((18)FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis","volume":"71","author":"A Lamarca","year":"2019","journal-title":"J Hepatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12885-015-1039-x","article-title":"Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity","volume":"15","author":"S T Feng","year":"2015","journal-title":"BMC Cancer"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/RCT.0b013e3182706562","article-title":"Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging","volume":"36","author":"S H Kim","year":"2012","journal-title":"J Comput Assist Tomogr"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis","volume":"7","author":"D TH De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"J K Heimbach","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"11","key":"ref81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0033-1344760","article-title":"Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients","volume":"45","author":"A H El Chafic","year":"2013","journal-title":"Endoscopy"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.gie.2016.04.039","article-title":"ERCP tissue sampling","volume":"84","author":"P Korc","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gie.2005.08.039","article-title":"Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study","volume":"63","author":"E L Fogel","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"07","key":"ref84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4253\/wjge.v6.i7.312","article-title":"Improved endoscopic retrograde cholangiopancreatography brush increases diagnostic yield of malignant biliary strictures","volume":"6","author":"F K Shieh","year":"2014","journal-title":"World J Gastrointest Endosc"},{"issue":"09","key":"ref85","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-1999-73","article-title":"Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography","volume":"31","author":"B Glasbrenner","year":"1999","journal-title":"Endoscopy"},{"issue":"03","key":"ref86","first-page":"254","article-title":"Brush cytology of ductal strictures during ERCP","volume":"63","author":"E Macken","year":"2000","journal-title":"Acta Gastroenterol Belg"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.40.5.671","article-title":"A prospective evaluation of cytology from biliary strictures","volume":"40","author":"J C Mansfield","year":"1997","journal-title":"Gut"},{"issue":"05","key":"ref88","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"G Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.gie.2011.09.020","article-title":"Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study","volume":"75","author":"P V Draganov","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref90","first-page":"465","article-title":"Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology","volume":"91","author":"M Sugiyama","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"ref91","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(00)70435-4","article-title":"Triple-tissue sampling at ERCP in malignant biliary obstruction","volume":"51","author":"J Jailwala","year":"2000","journal-title":"Gastrointest Endosc"},{"issue":"09","key":"ref92","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cgh.2012.05.025","article-title":"Tissue yield and diagnostic efficacy of fluoroscopic and cholangioscopic techniques to assess indeterminate biliary strictures","volume":"10","author":"D J Hartman","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"06","key":"ref93","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0016-5107(95)70004-8","article-title":"Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study","volume":"42","author":"V Pugliese","year":"1995","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"ref94","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1440-1746.2007.05037.x","article-title":"Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures","volume":"22","author":"Y Kitajima","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"04","key":"ref95","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.gie.2015.04.030","article-title":"Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review","volume":"82","author":"U Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.gie.2019.11.025","article-title":"Digital single-operator peroral cholangioscopy-guided biopsy versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized multicenter trial (with video)","volume":"91","author":"C Gerges","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"06","key":"ref97","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"L Aabakken","year":"2017","journal-title":"Endoscopy"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11605-017-3426-x","article-title":"Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System","volume":"22","author":"F Bagante","year":"2018","journal-title":"J Gastrointest Surg"},{"issue":"08","key":"ref99","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00268-017-4453-1","article-title":"Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes","volume":"42","author":"F Bagante","year":"2018","journal-title":"World J Surg"},{"issue":"07","key":"ref100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bjs.10556","article-title":"Surgical resection for Bismuth type IV perihilar cholangiocarcinoma","volume":"105","author":"T Ebata","year":"2018","journal-title":"Br J Surg"},{"issue":"04","key":"ref101","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","article-title":"Intrahepatic Cholangiocarcinoma","volume":"28","author":"R El-Diwany","year":"2019","journal-title":"Surg Oncol Clin N Am"},{"issue":"02","key":"ref102","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jamcollsurg.2008.10.017","article-title":"Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients","volume":"208","author":"H Lang","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"04","key":"ref103","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1245\/s10434-019-07968-7","article-title":"The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort","volume":"27","author":"A A Schnitzbauer","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"ref104","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s11605-017-3499-6","article-title":"Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy","volume":"21","author":"X F Zhang","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijsu.2019.05.006","article-title":"Extended resection of intrahepatic cholangiocarcinoma: A retrospective single-center cohort study","volume":"67","author":"F Bartsch","year":"2019","journal-title":"Int J Surg"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.suronc.2019.07.002","article-title":"Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches","volume":"33","author":"T Mizuno","year":"2020","journal-title":"Surg Oncol"},{"issue":"03","key":"ref107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00423-018-1649-2","article-title":"Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience","volume":"403","author":"F Rassam","year":"2018","journal-title":"Langenbecks Arch Surg"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"J N Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"07","key":"ref109","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"105","author":"B Le Roy","year":"2018","journal-title":"Br J Surg"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12957-020-01915-7","article-title":"Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases","volume":"18","author":"Y Chang","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"01","key":"ref111","doi-asserted-by":"crossref","first-page":"e1496","DOI":"10.1590\/0102-672020190001e1496","article-title":"BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA","volume":"33","author":"F JF Coimbra","year":"2020","journal-title":"Arq Bras Cir Dig"},{"issue":"08","key":"ref112","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jso.20535","article-title":"Surgical strategies in patients with gallbladder cancer: nihilism to optimism","volume":"93","author":"S S Sikora","year":"2006","journal-title":"J Surg Oncol"},{"issue":"01","key":"ref113","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/bjs.11035","article-title":"Systematic review of management of incidental gallbladder cancer after cholecystectomy","volume":"106","author":"K S\u00f8reide","year":"2019","journal-title":"Br J Surg"},{"issue":"04","key":"ref114","doi-asserted-by":"crossref","first-page":"350","DOI":"10.6004\/jnccn.2009.0027","article-title":"NCCN clinical practice guidelines in oncology: hepatobiliary cancers","volume":"7","author":"A B Benson 3rd","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"01","key":"ref115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12885-019-6507-2","article-title":"Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation","volume":"20","author":"K Yuza","year":"2020","journal-title":"BMC Cancer"},{"issue":"11","key":"ref116","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1245\/s10434-014-3527-7","article-title":"Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea","volume":"21","author":"S E Lee","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"04","key":"ref117","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00268-018-04876-x","article-title":"Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma","volume":"43","author":"F Bartsch","year":"2019","journal-title":"World J Surg"},{"issue":"01","key":"ref118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","article-title":"Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection","volume":"23","author":"G Spolverato","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"8732521","DOI":"10.1155\/2016\/8732521","article-title":"Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma","volume":"2016","author":"R Seidensticker","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"01","key":"ref120","first-page":"351","article-title":"Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results","volume":"36","author":"C Xu","year":"2019","journal-title":"Int J Hyperthermia"},{"issue":"11","key":"ref121","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1245\/s10434-013-3035-1","article-title":"Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma","volume":"20","author":"S J Zhang","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"02","key":"ref122","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.23605","article-title":"Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis","volume":"110","author":"N Amini","year":"2014","journal-title":"J Surg Oncol"},{"issue":"04","key":"ref123","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clinimag.2014.01.013","article-title":"Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome","volume":"38","author":"S R Butros","year":"2014","journal-title":"Clin Imaging"},{"issue":"05","key":"ref124","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jvir.2012.01.081","article-title":"Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma","volume":"23","author":"Y Fu","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"07","key":"ref125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jvir.2015.02.024","article-title":"Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"26","author":"K Han","year":"2015","journal-title":"J Vasc Interv Radiol"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"536","DOI":"10.21037\/jgo.2018.02.04","article-title":"Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015: an NCDB analysis","volume":"9","author":"A R Kolarich","year":"2018","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"ref127","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1007\/s00261-018-1656-3","article-title":"Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression","volume":"43","author":"E A Takahashi","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"03","key":"ref128","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.ejrad.2010.09.019","article-title":"Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection","volume":"80","author":"J H Kim","year":"2011","journal-title":"Eur J Radiol"},{"issue":"02","key":"ref129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/lt.24955","article-title":"Current status of liver transplantation for cholangiocarcinoma","volume":"24","author":"N Goldaracena","year":"2018","journal-title":"Liver Transpl"},{"issue":"01","key":"ref130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/TP.0000000000000286","article-title":"Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation","volume":"99","author":"M E Facciuto","year":"2015","journal-title":"Transplantation"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"V Vilchez","year":"2016","journal-title":"HPB (Oxford)"},{"issue":"05","key":"ref132","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study","volume":"259","author":"G Sapisochin","year":"2014","journal-title":"Ann Surg"},{"issue":"04","key":"ref133","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment","volume":"64","author":"G Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"05","key":"ref134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"K E Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period","volume":"12","author":"N S Becker","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"01","key":"ref136","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"S Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation","volume":"10","author":"C B Rosen","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/hep.15.30","article-title":"Liver transplantation in the management of perihilar cholangiocarcinoma","volume":"2","author":"A F Gulamhusein","year":"2015","journal-title":"Hepat Oncol"},{"issue":"05","key":"ref139","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease","volume":"267","author":"C G Ethun","year":"2018","journal-title":"Ann Surg"},{"issue":"06","key":"ref140","doi-asserted-by":"crossref","first-page":"e0156127","DOI":"10.1371\/journal.pone.0156127","article-title":"Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival","volume":"11","author":"H T Mantel","year":"2016","journal-title":"PLoS One"},{"issue":"08","key":"ref141","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"S M Weber","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"08","key":"ref143","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jvir.2013.03.019","article-title":"Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma","volume":"24","author":"C E Ray Jr","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000500894","article-title":"Poor Prognosis of Advanced Cholangiocarcinoma: Real-World Data from a Tertiary Referral Center","volume":"101","author":"C Koch","year":"2019","journal-title":"Digestion"},{"issue":"01","key":"ref145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11605-007-0312-y","article-title":"Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience","volume":"12","author":"N J Gusani","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"02","key":"ref146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.23781","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma","volume":"111","author":"L M Boehm","year":"2015","journal-title":"J Surg Oncol"},{"issue":"07","key":"ref147","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cncr.25625","article-title":"Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study","volume":"117","author":"M V Kiefer","year":"2011","journal-title":"Cancer"},{"issue":"03","key":"ref148","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijc.26407","article-title":"Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success","volume":"131","author":"T J Vogl","year":"2012","journal-title":"Int J Cancer"},{"issue":"07","key":"ref149","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/liv.13382","article-title":"Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study","volume":"37","author":"A Cucchetti","year":"2017","journal-title":"Liver Int"},{"issue":"08","key":"ref150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jvir.2018.04.001","article-title":"Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study","volume":"29","author":"A Gangi","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"ref151","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00259-018-3990-7","article-title":"A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and (90)Y-loaded glass microsphere selective internal radiation therapy","volume":"45","author":"V Manceau","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"05","key":"ref152","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00270-017-1871-2","article-title":"Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Na\u00efve Patients","volume":"41","author":"P Reimer","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"05","key":"ref153","first-page":"570","article-title":"Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review","volume":"6","author":"L Yang","year":"2015","journal-title":"J Gastrointest Oncol"},{"issue":"04","key":"ref154","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000500894","article-title":"Poor Prognosis of Advanced Cholangiocarcinoma: Real-World Data from a Tertiary Referral Center","volume":"101","author":"C Koch","year":"2020","journal-title":"Digestion"},{"issue":"12","key":"ref155","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"20","author":"O Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"04","key":"ref156","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00330-018-5729-z","article-title":"Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival","volume":"29","author":"S Marquardt","year":"2019","journal-title":"Eur Radiol"},{"issue":"01","key":"ref157","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial","volume":"6","author":"J Edeline","year":"2019","journal-title":"JAMA Oncol"},{"issue":"05","key":"ref158","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29824","article-title":"Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone","volume":"122","author":"I T Konstantinidis","year":"2016","journal-title":"Cancer"},{"issue":"01","key":"ref159","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis","volume":"41","author":"D P Al-Adra","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"04","key":"ref160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm8040458","article-title":"Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma","volume":"8","author":"K M Wronka","year":"2019","journal-title":"J Clin Med"},{"issue":"04","key":"ref161","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jvir.2016.12.1218","article-title":"Preoperative Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: Is Percutaneous Transhepatic Biliary Drainage Safer and More Effective than Endoscopic Biliary Drainage? A Meta-Analysis","volume":"28","author":"A Al Mahjoub","year":"2017","journal-title":"J Vasc Interv Radiol"},{"issue":"05","key":"ref162","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.hpb.2016.03.002","article-title":"Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma \u2013 a systematic review and meta-analysis","volume":"18","author":"A Hameed","year":"2016","journal-title":"HPB (Oxford)"},{"issue":"10","key":"ref163","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2468-1253(18)30234-6","article-title":"Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial","volume":"3","author":"R JS Coelen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"02","key":"ref164","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1055\/a-0990-9114","article-title":"Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinoma","volume":"8","author":"Y Ba","year":"2020","journal-title":"Endosc Int Open"},{"issue":"08","key":"ref165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jhbp.640","article-title":"Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma","volume":"26","author":"T Maeda","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"05","key":"ref166","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jgh.14050","article-title":"Multicenter study of endoscopic preoperative biliary drainage for malignant hilar biliary obstruction: E-POD hilar study","volume":"33","author":"Y Nakai","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"02","key":"ref167","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.surg.2016.08.008","article-title":"Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma","volume":"161","author":"K Komaya","year":"2017","journal-title":"Surgery"},{"issue":"06","key":"ref168","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5009\/gnl14243","article-title":"A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage","volume":"9","author":"K M Kim","year":"2015","journal-title":"Gut Liver"},{"issue":"05","key":"ref169","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1477-2574.2009.00090.x","article-title":"Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma","volume":"11","author":"T J Kennedy","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"02","key":"ref170","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00464-019-06813-y","article-title":"Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization","volume":"34","author":"S Miura","year":"2020","journal-title":"Surg Endosc"},{"issue":"01","key":"ref171","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2001.111388","article-title":"Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors","volume":"53","author":"R E Hintze","year":"2001","journal-title":"Gastrointest Endosc"},{"issue":"06","key":"ref172","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5107(02)70356-8","article-title":"Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life","volume":"56","author":"N S Abraham","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref173","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gie.2008.04.005","article-title":"Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach","volume":"69","author":"W H Paik","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"08","key":"ref174","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cgh.2008.03.028","article-title":"Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment","volume":"6","author":"S S Saluja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0009-9260(97)80275-9","article-title":"Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction","volume":"52","author":"W Schima","year":"1997","journal-title":"Clin Radiol"},{"issue":"01","key":"ref176","doi-asserted-by":"crossref","first-page":"e033576","DOI":"10.1136\/bmjopen-2019-033576","article-title":"The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study","volume":"10","author":"J Rees","year":"2020","journal-title":"BMJ Open"},{"issue":"01","key":"ref177","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00270-011-0103-4","article-title":"British Society of Interventional Radiology: Biliary Drainage and Stenting Registry (BDSR)","volume":"35","author":"R Uberoi","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(94)90455-3","article-title":"Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction","volume":"344","author":"A C Smith","year":"1994","journal-title":"Lancet"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(87)92733-4","article-title":"Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice","volume":"2","author":"A G Speer","year":"1987","journal-title":"Lancet"},{"issue":"02","key":"ref180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ajg.2016.512","article-title":"Plastic vs. Self-Expandable Metal Stents for Palliation in Malignant Biliary Obstruction: A Series of Meta-Analyses","volume":"112","author":"M A Almadi","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"02","key":"ref181","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.gie.2019.03.011","article-title":"Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture","volume":"90","author":"T H Lee","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"ref182","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1007\/s00464-016-4913-y","article-title":"Endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage: predictors of successful outcome in patients who fail endoscopic retrograde cholangiopancreatography","volume":"30","author":"R Z Sharaiha","year":"2016","journal-title":"Surg Endosc"},{"issue":"07","key":"ref183","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41395-018-0122-8","article-title":"EUS-Guided Biliary Drainage Versus ERCP for the Primary Palliation of Malignant Biliary Obstruction: A Multicenter Randomized Clinical Trial","volume":"113","author":"W H Paik","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref184","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gie.2018.03.012","article-title":"Stent placement by EUS or ERCP for primary biliary decompression in pancreatic cancer: a randomized trial (with videos)","volume":"88","author":"J Y Bang","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"09","key":"ref185","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/a-0659-9864","article-title":"Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline \u2013 Updated October 2017","volume":"50","author":"J M Dumonceau","year":"2018","journal-title":"Endoscopy"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"4726078","DOI":"10.1155\/2016\/4726078","article-title":"Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review","volume":"2016","author":"H Moole","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"01","key":"ref187","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/den.12320","article-title":"Comparison of percutaneous transhepatic biliary drainage and endoscopic biliary drainage in the management of malignant biliary tract obstruction: a meta-analysis","volume":"27","author":"X Q Zhao","year":"2015","journal-title":"Dig Endosc"},{"issue":"05","key":"ref188","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/00365529850172142","article-title":"Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures","volume":"33","author":"P Born","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"06","key":"ref189","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mge.2001.113381","article-title":"Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study","volume":"53","author":"G D De Palma","year":"2001","journal-title":"Gastrointest Endosc"},{"issue":"05","key":"ref190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0016-5107(98)70218-4","article-title":"Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage","volume":"47","author":"W H Chang","year":"1998","journal-title":"Gastrointest Endosc"},{"issue":"02","key":"ref191","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1499-3872(12)60150-7","article-title":"Clinical outcome in patients with hilar malignant strictures type II Bismuth-Corlette treated by minimally invasive unilateral versus bilateral endoscopic biliary drainage","volume":"11","author":"M Bulajic","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"01","key":"ref192","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mge.2002.125364","article-title":"Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents","volume":"56","author":"J L Cheng","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"04","key":"ref193","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.gie.2010.06.040","article-title":"Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment","volume":"72","author":"A Vienne","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.eclinm.2019.11.005","article-title":"Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction","volume":"18","author":"P R Harvey","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"01","key":"ref195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4253\/wjge.v6.i1.13","article-title":"Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction","volume":"6","author":"A O Tal","year":"2014","journal-title":"World J Gastrointest Endosc"},{"issue":"07","key":"ref196","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3748\/wjg.v23.i7.1278","article-title":"Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis","volume":"23","author":"H Moole","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"06","key":"ref197","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mge.2001.119605","article-title":"Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer","volume":"54","author":"T Zoepf","year":"2001","journal-title":"Gastrointest Endosc"},{"issue":"08","key":"ref198","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0043-124870","article-title":"Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial","volume":"50","author":"J Yang","year":"2018","journal-title":"Endoscopy"},{"issue":"05","key":"ref199","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"M E Ortner","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"ref200","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1572-0241.2005.00318.x","article-title":"Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy","volume":"100","author":"T Zoepf","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref201","first-page":"e000379","article-title":"PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer","volume":"3","author":"S P Pereira","year":"2018","journal-title":"ESMO Open"},{"issue":"04","key":"ref202","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/apt.15050","article-title":"Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma","volume":"49","author":"M A Gonzalez-Carmona","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"03","key":"ref203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5009\/gnl15175","article-title":"Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma","volume":"10","author":"R Wentrup","year":"2016","journal-title":"Gut Liver"},{"issue":"05","key":"ref204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.gie.2014.02.1030","article-title":"ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma","volume":"80","author":"D S Strand","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2050640616654037","article-title":"Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications","volume":"5","author":"W Dolak","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"03","key":"ref206","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cgh.2007.12.004","article-title":"Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy","volume":"6","author":"M Kahaleh","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"34","key":"ref207","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"E Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2018.11.015","article-title":"Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma","volume":"132","author":"T B Brunner","year":"2019","journal-title":"Radiother Oncol"},{"issue":"03","key":"ref209","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis","volume":"34","author":"R Tao","year":"2016","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review","volume":"195","author":"J Lee","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"20180688","DOI":"10.1259\/bjr.20180688","article-title":"Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review","volume":"92","author":"R Frakulli","year":"2019","journal-title":"Br J Radiol"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-7-67","article-title":"Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma","volume":"7","author":"B M Barney","year":"2012","journal-title":"Radiat Oncol"},{"issue":"04","key":"ref213","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"R V Tse","year":"2008","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref214","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2016.07.020","article-title":"Stereotactic body radiotherapy for primary hepatic malignancies \u2013 Report of a phase I\/II institutional study","volume":"121","author":"A A Weiner","year":"2016","journal-title":"Radiother Oncol"},{"issue":"01","key":"ref215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"N Kopek","year":"2010","journal-title":"Radiother Oncol"},{"issue":"05","key":"ref216","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"34","author":"T S Hong","year":"2016","journal-title":"J Clin Oncol"},{"issue":"03","key":"ref217","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00270-011-0249-0","article-title":"Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma","volume":"35","author":"D Schnapauff","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"44","key":"ref218","first-page":"748","article-title":"The diagnosis and treatment of cholangiocarcinoma","volume":"111","author":"A Vogel","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"16","key":"ref219","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"A M Horgan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.2017.35.4_suppl.225","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","volume":"35","author":"J Edeline","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) \u2013 a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"A Stein","year":"2015","journal-title":"BMC Cancer"},{"issue":"14","key":"ref222","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"J Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"06","key":"ref223","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial","volume":"5","author":"R T Shroff","year":"2019","journal-title":"JAMA Oncol"},{"issue":"04","key":"ref224","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"T Okusaka","year":"2010","journal-title":"Br J Cancer"},{"issue":"02","key":"ref225","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"J W Valle","year":"2014","journal-title":"Ann Oncol"},{"issue":"03","key":"ref226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4143\/crt.2014.308","article-title":"Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review","volume":"47","author":"J O Park","year":"2015","journal-title":"Cancer Res Treat"},{"issue":"S 05","key":"ref227","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"J W Valle","year":"2016","journal-title":"Ann Oncol"},{"issue":"15","key":"ref228","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2019.37.15_suppl.4003","article-title":"ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin \/ 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced \/ metastatic biliary tract cancers (ABC) previously-treated with cisplatin\/gemcitabine (CisGem) chemotherapy","volume":"37","author":"A Lamarca","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"ref229","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/annonc\/mdu162","article-title":"Second-line chemotherapy in advanced biliary cancer: a systematic review","volume":"25","author":"A Lamarca","year":"2014","journal-title":"Ann Oncol"},{"issue":"02","key":"ref230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejca.2012.08.003","article-title":"Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study","volume":"49","author":"T Walter","year":"2013","journal-title":"Eur J Cancer"},{"issue":"18","key":"ref231","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/cncr.29471","article-title":"Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Ent\u00e9rologues Oncologues","volume":"121","author":"B Brieau","year":"2015","journal-title":"Cancer"},{"issue":"05","key":"ref232","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"G K Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"09","key":"ref233","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New Horizons for Precision Medicine in Biliary Tract Cancers","volume":"7","author":"J W Valle","year":"2017","journal-title":"Cancer Discov"},{"issue":"00","key":"ref234","first-page":"JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair\u2013Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"0","author":"A Marabelle","journal-title":"Journal of Clinical Oncology"},{"key":"ref235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"D T Le","year":"2017","journal-title":"Science"},{"issue":"26","key":"ref236","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"D T Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"01","key":"ref237","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","article-title":"Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma","volume":"120","author":"B Goeppert","year":"2019","journal-title":"Br J Cancer"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41571-018-0115-y","article-title":"Fibroblast growth factor receptors as treatment targets in clinical oncology","volume":"16","author":"M Katoh","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"02","key":"ref239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00080","article-title":"Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype","author":"A Jain","year":"2018","journal-title":"JCO Precision Oncology"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/ncomms7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"D Sia","year":"2015","journal-title":"Nat Commun"},{"issue":"03","key":"ref241","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","article-title":"Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma","volume":"36","author":"M Javle","year":"2018","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref242","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41416-018-0334-0","article-title":"Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma","volume":"120","author":"V Mazzaferro","year":"2019","journal-title":"Br J Cancer"},{"issue":"16","key":"ref243","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/1078-0432.CCR-18-3334","article-title":"Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors","volume":"25","author":"R Bahleda","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"05","key":"ref244","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"G K Abou-Alfa","year":"2020","journal-title":"The Lancet Oncology"},{"issue":"12","key":"ref245","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"E Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33997 cases: diagnostic implications and pitfalls","volume":"33","author":"J P Solomon","year":"2019","journal-title":"Mod Pathol"},{"issue":"03","key":"ref247","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"J S Ross","year":"2014","journal-title":"Oncologist"},{"issue":"08","key":"ref248","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children","volume":"378","author":"A Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies \u2013 a role beyond breast cancer","volume":"17","author":"D Y Oh","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"01","key":"ref250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.21037\/jgo.2017.10.02","article-title":"Investigation of targetable predictive and prognostic markers in gallbladder carcinoma","volume":"9","author":"A Neyaz","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-015-0155-z","article-title":"HER2\/neu-directed therapy for biliary tract cancer","volume":"8","author":"M Javle","year":"2015","journal-title":"J\u00a0Hematol Oncol"},{"issue":"05","key":"ref252","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0042-103498","article-title":"[Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer]","volume":"54","author":"E Czink","year":"2016","journal-title":"Z Gastroenterol"},{"issue":"08","key":"ref253","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations","volume":"373","author":"D M Hyman","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"ref254","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2019.37.15_suppl.3002","article-title":"Dabrafenib and trametinib in patients with tumors with BRAF V600E\/K mutations: Results from the molecular analysis for therapy choice (MATCH) Arm H","volume":"37","author":"A KS Salama","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"06","key":"ref255","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.21037\/jgo.2016.09.13","article-title":"Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review","volume":"7","author":"V Lavingia","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"02","key":"ref256","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.21037\/jgo.2017.01.06","article-title":"Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion","volume":"8","author":"J Kocsis","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"04","key":"ref257","doi-asserted-by":"crossref","first-page":"815","DOI":"10.21037\/jgo.2019.03.05","article-title":"Personalised approach in combined treatment of cholangiocarcinoma: a case report of healing from cholangiocellular carcinoma at stage IV","volume":"10","author":"T Bunyatov","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"06","key":"ref258","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"G K Abou-Alfa","year":"2020","journal-title":"The Lancet Oncology"},{"issue":"09","key":"ref260","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2017.04.001","article-title":"Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis","volume":"43","author":"A Celotti","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"ref261","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s11605-018-3861-3","article-title":"Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal Cholangiocarcinoma","volume":"22","author":"R Ramanathan","year":"2018","journal-title":"J Gastrointest Surg"},{"issue":"03","key":"ref262","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5582\/bst.2017.01107","article-title":"Preoperative biliary drainage versus direct surgery for perihilar cholangiocarcinoma: A retrospective study at a single center","volume":"11","author":"Y Cai","year":"2017","journal-title":"Biosci Trends"},{"issue":"02","key":"ref263","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.8950","article-title":"Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma","volume":"100","author":"O Farges","year":"2013","journal-title":"Br J Surg"},{"issue":"46","key":"ref264","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.3748\/wjg.v19.i46.8731","article-title":"Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy","volume":"19","author":"J J Xiong","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref265","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12957-019-1656-y","article-title":"A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction","volume":"17","author":"L Wang","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"04","key":"ref266","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00423-016-1427-y","article-title":"The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy","volume":"401","author":"Y Kishi","year":"2016","journal-title":"Langenbecks Arch Surg"},{"issue":"01","key":"ref267","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.gie.2012.02.048","article-title":"Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial","volume":"76","author":"A Sangchan","year":"2012","journal-title":"Gastrointest Endosc"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1589-7854.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:53:01Z","timestamp":1726656781000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1589-7854"}},"subtitle":["Langversion 2.0 \u2013 Juni 2021 \u2013 AWMF-Registernummer: 032-053OL"],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":263,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,2,11]]},"published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1589-7854","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"type":"print","value":"0044-2771"},{"type":"electronic","value":"1439-7803"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}